Clinical Trial Update: An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

View source ↗

Summary

An open-label, non-interventional study assessing how adjuvant aromatase inhibitors affect bone mineral density and fracture risk in postmenopausal women with e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer, Osteoporosis | Status: COMPLETED